News

News
techshare
VitaDX was delighted to attend the TechShare Campus in Lisbon
23 juin 2022 -

VitaDX was delighted to attend the TechShare Campus in Lisbon as part of Euronext pre-IPO program and to be one of the 132 Tech companies from 10…

IFODS
International and French Oncology Days
22 juin 2022 -

VitaDX was very delighted to participate in the "Biotech in Oncology" exchange on the theme of accelerating oncology projects.

JOUM22
JOUM 2022
17 juin 2022 -

VitaDX participated to the JOUM (Medical Onco-Urology Days) which took place from June 17 to 18, 2022 in Toulouse.

SASN
Tour of France SASN
15 juin 2022 -

As part of its Tour de France of the "Digital Health" acceleration strategy around the theme: health data, Allan Rodriguez - CEO of VitaDX…

asco2022
VitaDX is proud to announce that the abstract of its first clinical trial VISIOCYT 1 has been selected at ASCO 2022
11 juin 2022 -

VitaDX is proud to announce that the abstract of its first clinical trial VISIOCYT 1 has been selected at ASCO 2022.

VitaDX
May «Bladder Cancer Awareness Month»
31 mai 2022 -

On this last day of May «Bladder Cancer Awareness Month», the entire VitaDX team reiterates its support to patients by working every day to…

santé expo
SANTEXPO 2022
17 mai 2022 -

VitaDX was present at SANTEXPO 2022 to attend the Workshop "How to accelerate to Europe?"

conf
First public conference dedicated to bladder cancer, organized by the University Hospital of Rennes and the Eugène Marquis Center
12 mai 2022 -

VitaDX attended the first public conference dedicated to bladder cancer, organized by the University Hospital of Rennes and the Eugène Marquis…

rennes business
Interview with Allan Rodrigues - CEO of VitaDX by Destination Rennes Business
25 avril 2022 -

Allan Rodriguez - CEO of VitaDX was interviewed by Destination Rennes to present the startup VitaDX and its in vitro diagnostic medical device…